Your browser doesn't support javascript.
loading
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype.
Sallman, David A; McLemore, Amy F; Aldrich, Amy L; Komrokji, Rami S; McGraw, Kathy L; Dhawan, Abhishek; Geyer, Susan; Hou, Hsin-An; Eksioglu, Erika A; Sullivan, Amy; Warren, Sarah; MacBeth, Kyle J; Meggendorfer, Manja; Haferlach, Torsten; Boettcher, Steffen; Ebert, Benjamin L; Al Ali, Najla H; Lancet, Jeffrey E; Cleveland, John L; Padron, Eric; List, Alan F.
Afiliación
  • Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • McLemore AF; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Aldrich AL; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • McGraw KL; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Dhawan A; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Geyer S; Health Informatics Institute, University of South Florida, Tampa, FL.
  • Hou HA; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Eksioglu EA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Sullivan A; NanoString Technologies, Inc., Seattle, WA.
  • Warren S; NanoString Technologies, Inc., Seattle, WA.
  • MacBeth KJ; Celgene Corporation, San Francisco, CA.
  • Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Boettcher S; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
  • Ebert BL; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA.
  • Al Ali NH; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and.
  • Lancet JE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Cleveland JL; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Padron E; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • List AF; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Blood ; 136(24): 2812-2823, 2020 12 10.
Article en En | MEDLINE | ID: mdl-32730593
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Proteína p53 Supresora de Tumor / Linfocitos T Reguladores / Células Supresoras de Origen Mieloide / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Proteína p53 Supresora de Tumor / Linfocitos T Reguladores / Células Supresoras de Origen Mieloide / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article